期刊
BIOORGANIC & MEDICINAL CHEMISTRY
卷 27, 期 13, 页码 2801-2812出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2019.05.007
关键词
c-Met; Receptor tyrosine kinase; Antitumor activity; Sulfonylurea; Molecular docking; 4-Phenoxyquinolines
资金
- Natural Science Foundation of Shandong [ZR2019MB009]
- Fundamental Research Funds for the Central Universities
- NSRIF [201701]
- Natural Science Foundation of China [21672046, 21372054]
- Found from the Huancui District of Weihai City
Deregulation of receptor tyrosine kinase c-Met has been reported in human cancers and is considered as an attractive target for small molecule drug discovery. In this study, a series of 4-phenoxyquinoline derivatives bearing sulfonylurea moiety were designed, synthesized and evaluated for their c-Met kinase inhibition and cytotoxicity against tested four cell lines in vitro. The pharmacological data indicated that most of the tested compounds showed moderate to significant potency as compared with foretinib, with the most promising compound 13x (c-Met kinase IC50= 1.98 nM) demonstrated relatively good selectivity versus 10 other tyrosine kinases and remarkable cytotoxicities against HT460, MKN-45, HT-29 and MDA-MB-231 with IC50 values of 0.055 mu M, 0.064 mu M, 0.16 mu M and 0.49 mu M, respectively. The preliminary structure activity relationships indicated that a sulfonylurea moiety as linker as well as mono-EGWs (such as R1= 4-F) on the terminal phenyl rings contributed to the antitumor activity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据